These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23157587)

  • 1. HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationship.
    Asaftei S; Huskens D; Schols D
    J Med Chem; 2012 Dec; 55(23):10405-13. PubMed ID: 23157587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Viologen" dendrimers as antiviral agents: the effect of charge number and distance.
    Asaftei S; De Clercq E
    J Med Chem; 2010 May; 53(9):3480-8. PubMed ID: 20377249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphonate terminated PPH dendrimers: influence of pendant alkyl chains on the in vitro anti-HIV-1 properties.
    Pérez-Anes A; Spataro G; Coppel Y; Moog C; Blanzat M; Turrin CO; Caminade AM; Rico-Lattes I; Majoral JP
    Org Biomol Chem; 2009 Sep; 7(17):3491-8. PubMed ID: 19675905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R; Borkow G; Berchanski A; Lapidot A
    FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.
    Li J; Lepadatu AM; Zhu Y; Ciobanu M; Wang Y; Asaftei SC; Oupický D
    Bioconjug Chem; 2014 May; 25(5):907-17. PubMed ID: 24821372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K; Schols D
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
    Bridger GJ; Skerlj RT; Hernandez-Abad PE; Bogucki DE; Wang Z; Zhou Y; Nan S; Boehringer EM; Wilson T; Crawford J; Metz M; Hatse S; Princen K; De Clercq E; Schols D
    J Med Chem; 2010 Feb; 53(3):1250-60. PubMed ID: 20043638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acids.
    Pérez-Anes A; Stefaniu C; Moog C; Majoral JP; Blanzat M; Turrin CO; Caminade AM; Rico-Lattes I
    Bioorg Med Chem; 2010 Jan; 18(1):242-8. PubMed ID: 19942442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-lead CXCR4 antagonists with high anti-HIV activity.
    Fujii N; Tamamura H
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1198-202. PubMed ID: 11717804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationship of dendrimer microbicides with dual action antiviral activity.
    Tyssen D; Henderson SA; Johnson A; Sterjovski J; Moore K; La J; Zanin M; Sonza S; Karellas P; Giannis MP; Krippner G; Wesselingh S; McCarthy T; Gorry PR; Ramsland PA; Cone R; Paull JR; Lewis GR; Tachedjian G
    PLoS One; 2010 Aug; 5(8):e12309. PubMed ID: 20808791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development.
    Singh S; Malik BK; Sharma DK
    Chem Biol Drug Des; 2007 Mar; 69(3):191-203. PubMed ID: 17441905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties of new viologen-phosphorus dendrimers.
    Ciepluch K; Katir N; El Kadib A; Felczak A; Zawadzka K; Weber M; Klajnert B; Lisowska K; Caminade AM; Bousmina M; Bryszewska M; Majoral JP
    Mol Pharm; 2012 Mar; 9(3):448-57. PubMed ID: 22214284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic catanionic assemblies: in vitro anti-HIV activity of phosphorus-containing dendrimers bearing galbeta1cer analogues.
    Blanzat M; Turrin CO; Aubertin AM; Couturier-Vidal C; Caminade AM; Majoral JP; Rico-Lattes I; Lattes A
    Chembiochem; 2005 Dec; 6(12):2207-13. PubMed ID: 16317767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.
    Howard OM; Oppenheim JJ; Hollingshead MG; Covey JM; Bigelow J; McCormack JJ; Buckheit RW; Clanton DJ; Turpin JA; Rice WG
    J Med Chem; 1998 Jun; 41(13):2184-93. PubMed ID: 9632350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1.
    Doménech R; Abian O; Bocanegra R; Correa J; Sousa-Herves A; Riguera R; Mateu MG; Fernandez-Megia E; Velázquez-Campoy A; Neira JL
    Biomacromolecules; 2010 Aug; 11(8):2069-78. PubMed ID: 20690715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing anti-HIV, antibacterial, antifungal, micellar, and cytotoxic properties of tricarboxylato dendritic amphiphiles.
    Macri RV; Karlovská J; Doncel GF; Du X; Maisuria BB; Williams AA; Sugandhi EW; Falkinham JO; Esker AR; Gandour RD
    Bioorg Med Chem; 2009 Apr; 17(8):3162-8. PubMed ID: 19307123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of viologen-phosphorus dendrimers on acetylcholinesterase and butyrylcholinesterase activities.
    Ciepluch K; Weber M; Katir N; Caminade AM; El Kadib A; Klajnert B; Majoral JP; Bryszewska M
    Int J Biol Macromol; 2013 Mar; 54():119-24. PubMed ID: 23237795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azamacrocyclic metal complexes as CXCR4 antagonists.
    Tanaka T; Narumi T; Ozaki T; Sohma A; Ohashi N; Hashimoto C; Itotani K; Nomura W; Murakami T; Yamamoto N; Tamamura H
    ChemMedChem; 2011 May; 6(5):834-9. PubMed ID: 21312334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.
    Miller JF; Turner EM; Gudmundsson KS; Jenkinson S; Spaltenstein A; Thomson M; Wheelan P
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2125-8. PubMed ID: 20207537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.